Biocryst Pharmaceuticals buy TD Cowen
Start price
15.10.25
/
50%
€5.62
Target price
15.10.26
€25.82
Performance (%)
49.95%
Price
27.07.26
€8.43
Summary
This prediction is currently active. With a performance of 49.95% the BUY prediction by TD_Cowen is a big success. This prediction currently runs until 15.10.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 3.869% | 3.869% |
| iShares Core DAX® | 2,99 % | 3,22 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % |
| iShares S&P 500 | -0,01 % | 1,64 % |
Comments by TD_Cowen for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat